Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBesifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis
Expert Opinion in Pharmacotherapy, 09/14/09
Bertino JS et al. – The low minimum inhibitory concentrations and high attainment of pharmacodynamic targets with besifloxacin may contribute to a lower risk for the emergence of bacterial resistance, although further studies are needed. These data indicate that besifloxacin ophthalmic suspension 0.6% is an important new option for the treatment of bacterial conjunctivitis.
Joseph S Bertino, 09/24/09
| This article discusses a new opthalmic antibiotic besifloxacin and its use in bacterial conjunctivitis. Antibiotic resistance continues to be a major problem in treatment. Newer agents such as besifloxacin may be useful in drug resistant bacterial infections. Besifloxacin optimized the pharmacodynamic ratios needed to attain good bacterial cure, and to potentially prevent the development of resistance. In clinical trials, besifloxacin was used for a 5 day treatment, however, the FDA requested a 7 day treatment in the label, no reason given. |
Related Articles
Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing
Canadian Family Physician, 11/13/09
Relevance Score: 66%
Bacterial Coinfections in Lung Tissue Specimens From Fatal Cases of 2009 Pandemic Influenza A (H1N1)--United States, May-August 2009
JAMA, 11/04/09
Relevance Score: 45%
Bacterial growth rate and host factors as determinants of intracellular bacterial distributions in systemic Salmonella enterica infections
Infection and Immunity, 10/12/09
Relevance Score: 45%
Detection of bacterial contamination of apheresis platelets in a Chinese Blood Center
Transfusion Medicine, 11/09/09
Relevance Score: 44%
Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
Annals of Clinical Microbiology and Antimicrobials, 10/13/09
Relevance Score: 44%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
Journal of Clinical Pharmacy and Therapeutics, 03/19/10
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
Cochrane Reviews, 03/19/10
Article Search
Sponsor
Sponsor